25 related articles for article (PubMed ID: 24789922)
1. 1-Laurin-3-Palmitin as a Novel Matrix of Solid Lipid Particles: Higher Loading Capacity of Thymol and Better Stability of Dispersions Than Those of Glyceryl Monostearate and Glyceryl Tripalmitate.
Shi H; Huang S; He J; Han L; Zhang W; Zhong Q
Nanomaterials (Basel); 2019 Mar; 9(4):. PubMed ID: 30934814
[TBL] [Abstract][Full Text] [Related]
2. New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell.
Kashanian S; Azandaryani AH; Derakhshandeh K
Int J Nanomedicine; 2011; 6():2393-401. PubMed ID: 22114489
[TBL] [Abstract][Full Text] [Related]
3. Transdermal Anti-Inflammatory Delivery for Solid Lipid Nanoparticles of Ketoprofen by Microwave-Assisted Microemulsion.
Jagdale SC; Bafna MS; Chabukswar AR
Recent Adv Inflamm Allergy Drug Discov; 2022 Jan; ():. PubMed ID: 35081901
[TBL] [Abstract][Full Text] [Related]
4. Solid Lipid Nanoparticles Containing Dopamine and Grape Seed Extract: Freeze-Drying with Cryoprotection as a Formulation Strategy to Achieve Nasal Powders.
De Giglio E; Bakowsky U; Engelhardt K; Caponio A; La Pietra M; Cometa S; Castellani S; Guerra L; Fracchiolla G; Poeta ML; Mallamaci R; Cardone RA; Bellucci S; Trapani A
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067437
[TBL] [Abstract][Full Text] [Related]
5. Solid Lipid Nanoparticles for Dibucaine Sustained Release.
de M Barbosa R; Ribeiro LNM; Casadei BR; da Silva CMG; Queiróz VA; Duran N; de Araújo DR; Severino P; de Paula E
Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30441802
[TBL] [Abstract][Full Text] [Related]
6. Development and Statistical Optimization of Solid Lipid Nanoparticle Formulations of Fluticasone Propionate.
Amasya G; Şengel TÜrk CT; Badilli U; Tarimci N
Turk J Pharm Sci; 2020 Aug; 17(4):359-366. PubMed ID: 32939130
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs).
Tulbah AS; Lee WH
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681283
[TBL] [Abstract][Full Text] [Related]
8. A Liposomal Formulation for Improving Solubility and Oral Bioavailability of Nifedipine.
Bi Y; Lv B; Li L; Lee RJ; Xie J; Qiu Z; Teng L
Molecules; 2020 Jan; 25(2):. PubMed ID: 31947655
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine strategies to improve therapeutic agents for the prevention and treatment of preterm birth and future directions.
Taylor J; Sharp A; Rannard SP; Arrowsmith S; McDonald TO
Nanoscale Adv; 2023 Mar; 5(7):1870-1889. PubMed ID: 36998665
[TBL] [Abstract][Full Text] [Related]
10. Preparation, Statistical Optimization and
Mehrabani Yeganeh E; Bagheri H; Mahjub R
Iran J Pharm Res; 2020; 19(3):45-62. PubMed ID: 33680009
[TBL] [Abstract][Full Text] [Related]
11. Combination of Roll Grinding and High-Pressure Homogenization Can Prepare Stable Bicelles for Drug Delivery.
Matsuo S; Higashi K; Moribe K; Kimura SI; Itai S; Kondo H; Iwao Y
Nanomaterials (Basel); 2018 Dec; 8(12):. PubMed ID: 30513913
[TBL] [Abstract][Full Text] [Related]
12. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
Heiati H; Tawashi R; Phillips NC
J Microencapsul; 1998; 15(2):173-84. PubMed ID: 9532523
[TBL] [Abstract][Full Text] [Related]
13. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
14. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
Howard MD; Lu X; Jay M; Dziubla TD
Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design.
Dudhipala N; Veerabrahma K
Drug Dev Ind Pharm; 2015; 41(12):1968-77. PubMed ID: 25830370
[TBL] [Abstract][Full Text] [Related]
16. Development of highly stable nifedipine solid-lipid nanoparticles.
Barman RK; Iwao Y; Funakoshi Y; Ranneh AH; Noguchi S; Wahed MI; Itai S
Chem Pharm Bull (Tokyo); 2014; 62(5):399-406. PubMed ID: 24789922
[TBL] [Abstract][Full Text] [Related]
17. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
